Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial

This cohort study assesses the durability of protection against symptomatic COVID-19 among participants of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine trial.

Detalles Bibliográficos
Autores principales: Lin, Dan-Yu, Baden, Lindsey R., El Sahly, Hana M., Essink, Brandon, Neuzil, Kathleen M., Corey, Lawrence, Miller, Jacqueline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178430/
https://www.ncbi.nlm.nih.gov/pubmed/35675078
http://dx.doi.org/10.1001/jamanetworkopen.2022.15984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178430/
https://www.ncbi.nlm.nih.gov/pubmed/35675078
http://dx.doi.org/10.1001/jamanetworkopen.2022.15984

Ejemplares similares